The global aerosol market during the fourth quarter demonstrated stable pricing dynamics as supply-demand fundamentals remained balanced across key product categories. Pharmaceutical aerosol segments experienced steady activity, with respiratory therapeutic applications maintaining consistent demand supported by regulatory approvals for generic inhalation products that expanded market accessibility. Medical aerosol manufacturers sustained reliable production output while downstream healthcare sectors demonstrated stable procurement patterns for bronchodilator and corticosteroid delivery systems.
Personal care and household aerosol segments exhibited similar stability throughout the quarter, with demand from deodorant, hairspray, and household cleaning applications reflecting seasonal consumption patterns. Manufacturing capacity remained adequate to meet market requirements without supply constraints that might trigger pricing adjustments. Raw material costs for propellants, including hydrofluorocarbon alternatives and compressed gas systems, held relatively steady, providing predictable input cost structures for aerosol producers.
Industrial and automotive aerosol applications showed measured activity, with coating, lubricant, and adhesive delivery systems maintaining consistent demand from manufacturing sectors. Valve and actuator component availability remained sufficient, while aluminium and tinplate packaging supply conditions supported stable production economics. Distribution channels reported adequate inventory positions without excessive accumulation that would necessitate pricing corrections. Regulatory compliance costs for propellant reformulation and environmental standards remained manageable within existing pricing frameworks.